Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)


  • European Master in Vaccinology Dec. 23, 2019 11:03 PM

    Application for our European Master Erasmus+ dedicated to Vaccinology LIVE is now opened

  • Job opportunity: Project Manager Dec. 23, 2019 11:00 PM

    The Vaccine Formulation Institute (VFI) wishes to recruit a Project Manager to join the VFI Project Management Team in Berlin, Germany. Applications can be submitted until 31 January 2020 to

  • Courses and webinars from CORBEL Nov. 19, 2019 1:26 AM

    The EU funded project CORBEL (Coordinated Research Infrastructures Building Enduring Life-science Services) have open spots for webinars and courses:

  • Job opportunities in Lille, France Nov. 19, 2019 1:01 AM

    3 positions opened for 2020 in laboratory to work on alternative (host-directed) therapies of bacterial infections. PhD or engineer with strong backgoround in cell biology, immunity or bioinformatics wanted.

    For more information, click here


06 Feb.
Oxford, England

3rd Human Challenge Trials in Vaccine Development

07 Feb.
Oxford, England

3rd Human Challenge Trials in Vaccine Development

16 Mar.